Abstract: A patient positioning device has a robot arm and a patient receptacle held at the robot arm. The patient positioning device has a housing assembly for the robot arm. The housing assembly is provided with one or more housing units surrounding the robot arm at least partially. The one or more housing units are secured at the robot arm. The patient positioning device is provided with a shielding against ionizing radiation. At least one part of the shielding is arranged at the one or more housing units.

Abstract: According to the present disclosure, a surgical patient support provides support to a patient. The surgical patient support may include configuration to accommodate various patient body positions to provide a variety of access to the patient's body.

Abstract: A cremated remains remembrance system including a vase, an urn, a vase lid and a decorative ring. The vase has an opening formed therein. The vase has a first attachment mechanism. The urn in which cremated remains are placed. The urn may be placed at least partially in the vase opening. The vase lid is capable of engaging the first attachment mechanism to substantially close the vase opening. The decorative ring has an opening extending therethrough. The decorative ring is capable of engaging the first attachment mechanism to substantially cover the first attachment mechanism when the urn is not in the vase opening and the vase lid is not attached to the vase.

Abstract: A vibrotactile support with suppressed distortion and destructive interference having a rigid frame within which is tensioned a high-density material panel in a supportive configuration. A low-durometer, high specific gravity material user interface pad is placed on the high-density panel on the user-supporting side and a plurality of acoustic drivers are attached to the opposing side of the high-density material panel to transmit vibrations through the high-density material panel, the pad, and the user's skin. The acoustic drivers are supplied from an amplifier which is supplied from an electronic audio source. The amplifier may also drive a set of headphones for the user. The audio source may be from any known electronic audio source, including audio-visual presentations. Various shapes and configurations of the vibrotactile support are possible. For non-limiting examples, the vibrotactile support may be configured as a lounge chair, upright chair, baby cradle, or flat bed.

Abstract: An apparatus for toning an exerciser's buttocks comprises, a base having a front end region and a rear end region; a seat guide; and a force-transmitting mechanism for supporting the seat guide on the base for guided movement under tension from a raised position, along an forward inclined trajectory in which the seat guide is continuously lowered in elevation to a lowered position. The exerciser sits on the seat guide and controls its downward and upward motion by tensioning and thereby exercising the users gluteus maximus, medius, and gluteus minimus muscles.

Abstract: A pivoting lower limb therapy device formed from a lever frame having a handle portion integral with its proximal end and a first orthotic portion adjacent to its distal end, a base frame having a second orthotic portion integral with its proximal frame end and a surface support portion integral with its distal frame end, with the lever frame rotatably attached to the base frame so as to permit the first orthotic portion to move across two dimensions relative to the second orthotic portion in response to an exertion of mechanical force on the handle portion. The pivoting lower limb therapy device may also include a strap assembly connected to and extending between the proximal end of the lever frame and the proximal frame end of the base frame so as to exert mechanical force on the two frame members.

Abstract: A foot stretching/checkup device includes: a motor unit; a footrest unit including a lower footrest configured to be rotated about a first rotation axis, an upper footrest configured to be rotated about a second rotation axis and a connecting member connecting the upper footrest and the lower footrest; and a coupling unit including an arm portion rotated by the motor unit and a rotary coupler coupled to the upper footrest. The upper footrest is configured to be rotated by a predetermined angle about the second rotation axis by the rotation of the arm portion. The lower footrest is configured not to be rotated about the first rotation axis by rotation of the arm portion until the upper footrest is rotated by the predetermined angle.

Abstract: The present disclosure relates to an assisted exoskeleton rehabilitation device, comprising: a back structure comprising a back crossbeam, a back supporting panel with an adjustable length, and a shoulder pneumatic muscle element mounted on the back supporting panel; an arm structure; a shoulder joint assembly, by which the arm structure is connected to an upper end of the back structure; and a waist structure. An upper end of the back supporting panel is fixedly connected to the back crossbeam, and a lower end thereof is fixedly connected to the waist structure. The shoulder joint assembly comprises a curved shoulder joint connecting panel, a shoulder traction wheel, a shoulder traction line, a first hinge mechanism and a second hinge mechanism.

Abstract: An assist device includes a first body-worn unit, a second body-worn unit, a belt body, an actuator, and a controller. The actuator includes a pulley and a motor that causes the pulley to reel and unreel a part of the belt body. The controller is configured to execute a mode switching process of switching a control mode of the motor to one a restriction mode in which a maximum rotation speed of the motor is restricted to a predetermined rotation speed and a normal mode in which the motor is operated within a rotation speed range higher than the predetermined rotation speed.

Abstract: An assistive device for stair-climbing assistance includes a powered rail-sliding platform that assists its user through a unique human interface. The device provides powered assistance (a gentle pulling force) and protection (through a safety belt) to help users climb or descend stairs.

Abstract: The present invention provides a limb compression device, including: a main body having a first surface where a support portion wrapping around a portion of a limb is provided, and a second surface where a fixing shaft fixing a cuff wrapping around a remaining portion of the limb is mounted; a drive motor coupled to the main body; a reduction gear unit coupled to a drive shaft of the drive motor; a cuff fixing drum fixing the cuff, and having a first end coupled to the reduction gear unit and a second end coupled to the main body such that the cuff fixing drum winds and unwinds the cuff; and the cuff including a first end fixed to the cuff fixing drum and a second end wound around the fixing shaft via the support portion of the main body so as to wrap around the remaining portion of the limb.

Abstract: A system includes a guidance device that provides feedback to a user to compress a patient's chest at a rate of between about 90 and 110 compressions per minute and at a depth of between about 4.5 centimeters to about 6 centimeters. The system includes a pressure regulation system having a pressure-responsive valve that is configured to be coupled to a patient's airway. The pressure-responsive valve is configured to remain closed during successive chest compressions in order to permit removal at least about 200 ml from the lungs in order to lower intracranial pressure to improve survival with favorable neurological function. The pressure-responsive valve is configured to remain closed until the negative pressure within the patient's airway reaches about ?7 cm H2O, at which time the pressure-responsive valve is configured to open to provide respiratory gases to flow to the lungs through the pressure-responsive valve.

Abstract: Hand-controlled physiotherapy equipment contains: a first electrode and a second electrode which are connected with living creatures so as to form a closed loop, an electrical stimulation system, a signal receiving unit, and a signal identification unit. The electrical stimulation system includes a sensing unit. The signal receiving unit is connected with the sensing unit in a wired manner or a wireless manner, the signal identification unit is configured to transform loop signals into time series signals, wherein when each of the time series signals has a specific interruption signal and a specific recovery signal, each time series signal triggers a mode adjustment signal in a control module. The control module includes a predetermined comparison database, and the comparison database has multiple set modes, wherein the multiple set modes respectively have multiple interruption signals and multiple recovery signals.

Abstract: An electromagnetic physiotherapy apparatus of conception and governor vessels includes an electromagnetic generating device, and a torso model structure. The torso model structure is electrically connected to the electromagnetic generating device, and is configured to be worn by the user, and the torso model structure is provided with electromagnetic diaphragms at positions corresponding to acupuncture points and tissues of a human body. The torso model structure includes a head unit, a chest unit, a waist unit and a lower abdomen unit, and the head unit, the chest unit, the waist unit and the lower abdomen unit are connected through a main torso. A physiotherapy method of conception and governor vessels includes: enabling a bionic electromagnetism to synchronously act on a neuron area, a block and a chain to promote connections between synapses of the neuron area, the block and the chain.

Abstract: In certain embodiments, a vial adaptor for removing liquid contents from a vial comprises a piercing member and a bag. The bag can be contained within the piercing member such that the bag is introduced to the vial when the vial adaptor is coupled with the vial. In some embodiments, the bag expands within the vial as liquid is removed from the vial via the adaptor, thereby regulating pressure within the vial. In other embodiments, a vial comprises a bag for regulating pressure within the vial as liquid is removed therefrom. In some embodiments, a vial adaptor is coupled with the vial in order to remove the liquid. In some embodiments, as the liquid is removed from the vial via the adaptor, the bag expands within the vial, and in other embodiments, the bag contracts within the vial.

Abstract: The present invention relates, in part, to hydrophobically-modified polymers and foams and their use in the control of bleeding.

Abstract: The disclosure encompasses systems and methods for performing high temperature and high humidity curing of tablets using air flow delivered from a recirculating air handler to a pan coater of a tablet coating device. The recirculating air handler may be integrated into a preexisting tablet coating device so that the air flow may be delivered by the preexisting air handler or by the recirculating air handler as desired.

Abstract: The invention relates to a body (4) intended for being mounted to/on an outlet of a container with a fluid, adapted for receiving a container (1) for administering a solid medicinal product or a dietary supplement together with a fluid. The invention further relates to the container (1) for administering a solid medicinal product or a dietary supplement together with a fluid, intended for being placed, at least partly, in the body (4) intended for being mounted to a container with a fluid. The invention further relates to a device for administering a solid medicinal product or a dietary supplement together with a fluid, comprising the body (4) for receiving the container (1), intended for being mounted on a container with a fluid, and the container (1) for administering a solid medicinal product or a dietary supplement together with a fluid.

Abstract: Mobile systems and methods are adapted to control and document prehospital patient care reports and communication of patient status to a receiving medical treatment facility. The systems and methods relate to systems and methods for managing, recording, and administering drugs such as narcotics in an ambulatory and/or emergency environment.

Abstract: Disclosed is an NGT system, the system comprises a nasogastric tube having a diameter and length configured to pass through an esophagus such that the lumen of the NGT maintains fluid communication with a portion of the digestive tract, and a digestive tract sensor operatively associated with the NGT, the digestive tract sensor configured to sense from inside the body and transmit signals in response to one or both of conditions relating to nourishment states of the digestive tract, and positioning of the NGT.

Abstract: Disclosed is a connector for connecting a sealed, flexible nutrition pouch to the hydration system of a user's protective mask, that allows the nutrition pouch to remain sealed until the user intends to consume the product inside of the nutrition pouch, enables resealing of the pouch after it has initially been opened, and allows connection of the nutrition pouch to the user's hydration system. The connector comprises a multi-piece body having an inlet end that may be manually attached to the outlet of the nutrition pouch without breaking the seal covering the outlet of the nutrition pouch. The connector likewise has an outlet end configured for attachment to an adapter on the user's fluid delivery system.

Abstract: Improved feeding set connectors and cassettes are disclosed for use with peristaltic infusion pumps for safely delivering enteral nutritional fluids to a patient. The connectors provide an easy to use “pump-to-set” integration or “keying” system for specific reusable infusion pumps and their matching feeding sets, and can be utilized by medical professionals having various skill levels. The inventive feeding set cassettes can prevent accidental free flow of enteral fluids into a patient, even upon inadvertent release of the connector from the pumping mechanism.

Abstract: A polymerisable, radiation curable composition comprising (i) monomers comprising: (a) at least one acrylic acid ester having an additional carboxy group, acrylic acid ester having at least one additional anhydride group of carboxy groups, and/or derivative of the afore-mentioned acrylic acid esters, (b) at least one di-functional acrylate having a bivalent alicyclic group and/or at least one di-functional methacrylate having a bivalent alicyclic group, and (c) optionally, at least one disubstituted 4,4?-di(oxabenzene) dialkyl methane of formula I, and (ii) at least one further component comprising: (d) at least one photoinitiator for the UV and/or Vis spectral region or a photoinitiator system. The composition is suitable for producing dental prosthetic parts, orthopaedic appliances or dental pre-forms, having a) a flexural strength 50 MPa, b) an E-modulus ?1500 MPa, c) a bending fracture ?1.1 MPa m1/2, and/or d) a fracture work >250 J/m2 DIN EN ISO 20795-2.

Abstract: A stoma powder composition is formulated with at least one moisture absorbing material and at least one skin health ingredient. The stoma powder composition is configured to absorb moisture from peristomal skin while improving peristomal skin health.

Abstract: Disclosed by the present invention are an aqueous polyurethane functional mask substrate and an application thereof. Two kinds of water-based polyurethane dispersions are used as the main components of the mask substrate. The transdermal penetration and absorption of functional ingredients such as whitening, moisturizing and anti-aging ingredients in facial mask products are promoted by means of the special cross-linked structures of polyurethane films. During use, a mask is evenly applied to the face; and after the mask dries, the entire mask may be removed directly or removed after being moistened using water. The mask substrate according to the present invention is also applicable to body masks such as a hand mask, a neck mask and a back mask.

Abstract: The present disclosure provides gel stick compositions. The gel stick compositions comprise i) one or more emollients; ii) one or more emulsifiers; iii) one or more block copolymers; iv) one or more co-gellants; and v) one or more antioxidants. Inclusion of a “co-gellant” to the described gel stick compositions provides several synergistic advantages of the resultant compositions.

Abstract: Embodiments herein provide a cosmetic or dermatologic composition comprising a plurality of multiparticulated particles, wherein the multiparticulated particles comprise a plurality of coated active ingredient particles, each coated particle comprising at least one active ingredient having a core and a coating thereon. The multiparticulated particles further comprise a plurality of uncoated active ingredient particles, the uncoated particles comprising at least one active ingredient having a core. In further embodiments, the coated particles and the uncoated particles have the same or different active ingredient cores. The present invention further provides a method of protecting skin or hair by applying the cosmetic composition according to the invention.

Abstract: An oil-in-water emulsion composition contains a) at least one liquid continuous aqueous phase (X) containing alcohol in water; b) at least one dispersed fatty phase (Y), of at least one oil; c) stabilizing particles (Z), being selected from solid particles and soft-gel particles. The oil-in-water emulsion composition is useful as a topical sanitizing composition.

Abstract: The present invention relates generally to sun protection compositions for application to the skin, and in particular sunscreen formulations comprising zinc oxide and other components in a water-in-silicone/oil inverted emulsion system.

Abstract: The present invention provides a method for producing a glyceryl ether-containing composition, the method including: a deodorization step for bringing a glyceryl ether-containing product selected from the group consisting of a monohexyl glyceryl ether-containing product, a monocyclohexyl glyceryl ether-containing product and a mixture thereof into contact with water vapor in an environment having a reduced pressure of 0.10 kPa or more and 10 kPa or less for 60 minutes or more and 600 minutes or less; and an addition step for adding 0.05 to 0.30 parts by mass of an antioxidant containing d-?-tocopherol to 100 parts by mass of the glyceryl ether-containing product, and also provides a glyceryl ether-containing composition containing specific amounts of a specific glyceryl ether and an antioxidant containing d-?-tocopherol.

Abstract: Oral care compositions including dicarboxylic acid and tin. Oral care kits including a first oral care composition with tin and a second oral care composition with dicarboxylic acid. Oral care compositions including tin and dicarboxylic acid that provide an enhanced antierosion benefit, a stain prevention benefit, and/or a stain removal benefit.

Abstract: A process for producing a bio-based surfactant comprising an alkyl disulphate salt comprises the steps of methanolysis of medium chain length polyhydroxyalkanoic acid (mcl-PHA) to provide hydroxy fatty acid methyl ester monomers (HFAME's), reduction of the HFAME's to provide 1,3 alkyl diols, sulphation of the 1,3 alkyl diols to provide 1,3 alkyl disulphates, and neutralisation of the alkyl disulphates to provide a bio-based surfactant comprising 1,3 alkyl disulphate salt. A bio-based surfactant comprising a mixture of medium chain length 1,3 alkyl disulphate salts is also described.

Abstract: A shampoo composition delivering consumer desired lather, cleaning and viscosity comprising from about 8 wt % to about 35 wt % of decyl glucoside having an average alkyl chain length of about C10; from about 0.25 wt % to about 1.0 wt % alkyl glucoside with an average alkyl chain of C12 and greater; from about 0.4% to 2.0% of a gum selected from non-ionic and anionic gums consisting of xanthan gum, sclerotium gum, guar gum, locust bean gum, tragacanth gum, acacia gum, agar gum, algin gum, gellan gum, carob gum, karaya gum biosacharide gum, calcium carrageenan, potassium carrageenan, sodium carrageenan, potassium alginate, ammonium alginate, calcium alginate and any combination thereof.

Abstract: A composition contains a cell culture medium and, as an active ingredient, albumin, hyaluronic acid or collagen. The composition is useful as a cosmetic or pharmaceutical purpose for alleviating, preventing or treating skin wounds, skin diseases or skin conditions, by enhancing recovery capability of cells. The cell culture medium may be a serum-free medium.

Abstract: The present invention generally relates to skin care and, in particular, to systems and methods for treating and/or preventing acne. Acne is believed to be caused by a combination of factors, including Propionibacterium acnes bacteria, excess sebum production, and inflammation from the immune response (e.g., in response to P. acnes). Certain aspects of the invention are thus directed to one or more compositions that collectively target these factors, although it should be understood that a single composition may target more than one factor at a time. For instance, in one set of embodiments, a treatment may include a first composition that cleans the skin, a second composition that contains growth inhibitor of P. acnes (e.g., for use during the day), and a third composition that inhibits sebum production (e.g., for use during the night). One or more of these may contain other components, such as anti-inflammatory agents, moisturizers, topical anti-microbial agents (e.g., salicylic acid), or the like.

Abstract: The present invention relates to the use of a combination of D-panthenol, allantoin and oat kernel extract in protecting mast cells thereby anti-allergy. The present invention also provides an anti-allergic cosmetic composition having the function of protecting mast cells, comprising a combination of D-panthenol, allantoin and oat kernel extract, and ingredients commonly used in cosmetics; and an anti-allergic cosmetic method, comprising applying the cosmetic composition to the skin.

Abstract: A shampoo composition comprising a nonionic surfactant, and a cationic guar having a weight average molecular weight of from about 800,000 g/mol to about 5,000,000 g/mol, and a charge density of from about 0.1 meg/g to about 2.5 meg/g. The shampoo is phase stable and delivers a consumer desirable in use viscosity while still providing cleaning, moisture and slip feel hair benefits.

Abstract: The present invention relates to a shear-thinning or pseudoplastic cosmetic composition. Zeta potentials may be balanced such that a first ratio of the first zeta potential to the second zeta potential may be approximately 1:2. A second ratio of the first zeta potential to the third zeta potential may be approximately 1:2. And, a third ratio of the second zeta potential to the third zeta potential may be approximately 1:1. Balancing zeta potentials may ensure the shear-thinning cosmetic composition can dispense in its original viscous form and as a fine mist through a single device.

Abstract: A personal care formulation is provided comprising: multistage polymer, comprising: acrylate rich stage comprising: (a) structural units of monoethylenically unsaturated non-ionic, acrylate rich stage monomer selected from C1-22 alkyl (meth)acrylates and mixtures thereof; and (b) carbosiloxane rich stage, comprising: structural units of carbosiloxane monomer of formula (I), wherein a is 0 to 3; wherein d is 0 or 1; wherein R1 is selected from hydrogen, C1-10 alkyl group and aryl group; wherein R2 is selected from hydrogen and C1-10 alkyl group; wherein R8 is —O—Si(CH3)2—O—Si(CH3)3 group; wherein Y is selected from formula (II), (III) and (IV); wherein R4 and R6 are selected from hydrogen and methyl group; wherein R3 and R5 are a C1-10 alkylene group; wherein R7 is C1-10 alkyl group; wherein b is 0 to 4 and wherein c is 0 or 1.

Abstract: The invention discloses an eyelash liquid eyeliner, wherein the raw materials comprise the following components in parts by weight: 50-60 parts of ethyl hexyl acrylate copolymer, 30-40 natural beeswax, 10-12 carnauba wax, 8-12 polyvinylpyrrolidone, 5-7 shellac, 1-3 black talc powder, 20-30 polyvinyl alcohol, 20-30 of silicone resins, 10-12 of codariocalyx motorius saponin extract, 5-7 dual-directional regulation growth promotion factors, 1-3 antifreeze, 1-3 coloring agent, 1-3 preservative, and 5-7 antioxidant. Components in the liquid eyeliner are replaced with natural substances of the natural beeswax, the carnauba wax, the shellac and the like, and the eyelash liquid eyeliner is safe to skin. Besides, organic silicone resins are added, so that the condition that the eyelash liquid eyeliner is broken up when being in contact with water can be effectively avoided, the organic silicone resin can effectively block ultraviolet rays and prevent the ultraviolet rays from destroying roots of eyelashes.

Abstract: Disclosed is a transfer-resistant and long-lasting cosmetic composition and system, and a method for applying the cosmetic composition. The disclosed composition includes an oil phase comprising a silicone resin film former and a silicone-based plasticizer, an aqueous phase comprising an acrylate copolymer resin, and a hydrophilic gelling agent. The disclosed system includes an anhydrous basecoat comprising a silicone resin, and a topcoat that includes an oil phase comprising a silicone resin film former and a silicone-based plasticizer, an aqueous phase comprising an acrylate copolymer resin, and a hydrophilic gelling agent.

Abstract: Provided is a composition comprising a novel strain, a lysate thereof or a culture product thereof, which can demonstrate excellent effects in strengthening skin barrier, moisturizing skin, enhancing skin elasticity or anti-aging, and can be used for a cosmetic composition or health functional food.

Abstract: Provided is a composition comprising a novel strain, a lysate thereof or a culture product thereof, which can demonstrate excellent effects in strengthening skin barrier, moisturizing skin, enhancing skin elasticity or anti-aging, and can be used for a cosmetic composition or health functional food.

Abstract: The present invention provides a mucoadhesive patch for attachment to a mucosal surface in a patient, the patch comprising a fibrous polymeric mat substrate and a plurality of polymeric flock particles that are attached to the substrate.

Abstract: Disclosed is a mucoadhesive pharmaceutical composition comprising a poly-ionic complex of chitosan and a polyacrylic acid polymer. As an oral formulation, the composition has the extended retention time in the gastrointestinal tract by its mucoadhesive and swelling properties, which is useful as sustained release formulations, retentive formulations of active ingredients with limited absorption regions, and active ingredients with pH dependent solubility.

Abstract: The present invention provides a stable, aqueous injectable solution comprising epinephrine or its pharmaceutically acceptable salt, a sulfite antioxidant, butylated hydroxyl anisole, an organic acid and a chelating agent, wherein the solution is free of an inorganic acid and an inorganic base. The invention also provides a method of treating the septic shock by intravenous administration of stable aqueous injectable solution comprising epinephrine or its pharmaceutically acceptable salt, a sulfite antioxidant, butylated hydroxyl anisole, an organic acid and a chelating agent, wherein the solution is free of an inorganic acid and an inorganic base.

Abstract: The present technology relates to depot assemblies for the controlled, sustained release of a therapeutic agent. The assembly can include a depot having a therapeutic region comprising an analgesic, and a control region comprising a bioresorbable polymer and a releasing agent mixed with the polymer. The releasing agent may be configured to dissolve when the depot is placed in vivo to form diffusion openings in the control region. The depot may be configured to be implanted at a treatment site in vivo and, while implanted, release the therapeutic agent at the treatment site for no less than 3 days. The assembly further includes a fixation portion coupled to the depot and configured to facilitate attachment of the depot assembly to tissue at or adjacent to the treatment site.

Abstract: The invention provides stable liquid formulations containing naloxone, a pharmaceutically acceptable salt or a derivative thereof. The invention further provides methods for treating opioid overdose, opioid dependence, and congenital insensitivity to pain with anhidrosis by administering the liquid formulations of the present invention intranasally to a patient in need thereof. Further, the invention provides a method of treating opioid dependence, opioid overdose, and congenital insensitivity to pain with anhidrosis by administering intranasally the naloxone formulations of the present invention.

Abstract: Amorphous solid dispersions and pharmaceutical compositions of the protein kinase inhibitor nilotinib. The pharmaceutical compositions may be used in methods of treating a proliferative disorder such as cancer. In particular, the present disclosure provides a pharmaceutical composition in the form of an orally disintegrating tablet. In some embodiments, the pharmaceutical compositions can be administered without regard to food consumption. In other embodiments, the pharmaceutical compositions can be administered at a significantly lower dose as compared to a commercially available immediate-release nilotinib formulation, while providing a comparable therapeutic effect.

Abstract: An orally disintegrating dosage form of a proton pump inhibitor, methods for its production and use thereof are provided. The dosage form includes a plurality of pellets containing a proton pump inhibitor admixed with a disintegrant to afford rapid disintegration in the oral cavity after administration.